Trials / Completed
CompletedNCT01243450
Bioequivalence Study of Generic Tretinoin 0.04% Microsphere Gel, 0.04% Retin-A Micro® and Placebo
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 958 (actual)
- Sponsor
- Spear Pharmaceuticals · Industry
- Sex
- All
- Age
- 12 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The objective will be to assess clinical bioequivalence of 0.1% Retin-A Micro® Gel and Spear Pharmaceutical's generic 0.1% Tretinoin Microsphere Gel with a placebo arm.
Detailed description
Acne study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tretinoin | Treatment of acne |
| DRUG | placebo | treatment of acne |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2010-11-18
- Last updated
- 2020-01-03
- Results posted
- 2014-11-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01243450. Inclusion in this directory is not an endorsement.